Thursday, August 05, 2021 3:52:37 PM
17.50 Held ok
so far so good. big jump off the 17.50 quadruple bottom, now reaches the resistance zone (19-22) needs to be watched with caution here, the pattern going down from 28 has been one of 2 and 3 dollar bounces up followed by 5 and 6 dollar downwaves. the finished bottom will be reached at some point. Is it going to be 17.50? cant say. but the bounce now, 2 or 3 dollars is this 20 dollar area, watch closely now to see if it struggles around 20,rolls over and starts the next downwave to retest the 18/17 again, and might continue to the 16/15 targets...IF the rollover pattern is still going downwave. Its always encouraging to see nice bounces off a bottom target step,but we need now to watch for the next part of the pattern to come.
Holding support now at 18 becomes critical to watch for. rally follow thru needs to push beyond 20/21/22 and start testing 23 and 24 to become more bullish. and regain the momentum. There is a shoulder around 20 area that is currently resistance but would become support, if the rally reaches the 24 target zone and then pulls back to hold at 20. and thats how the bullish pattern develops. watch the support area now around 18 to show any strength or not.
a jump into resistance
so far so good. big jump off the 17.50 quadruple bottom, now reaches the resistance zone (19-22) needs to be watched with caution here, the pattern going down from 28 has been one of 2 and 3 dollar bounces up followed by 5 and 6 dollar downwaves. the finished bottom will be reached at some point. Is it going to be 17.50? cant say. but the bounce now, 2 or 3 dollars is this 20 dollar area, watch closely now to see if it struggles around 20,rolls over and starts the next downwave to retest the 18/17 again, and might continue to the 16/15 targets...IF the rollover pattern is still going downwave. Its always encouraging to see nice bounces off a bottom target step,but we need now to watch for the next part of the pattern to come.
Holding support now at 18 becomes critical to watch for. rally follow thru needs to push beyond 20/21/22 and start testing 23 and 24 to become more bullish. and regain the momentum. There is a shoulder around 20 area that is currently resistance but would become support, if the rally reaches the 24 target zone and then pulls back to hold at 20. and thats how the bullish pattern develops. watch the support area now around 18 to show any strength or not.
a jump into resistance
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
